Showing 1381-1390 of 23108 results for "".
Changing Your Outcome: Converting Bad Assets to Good
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/changing-your-outcome-converting-bad-assets-good/8138/If you are in your 50s and have fallen behind in building your personal wealth, your most powerful strategy to “catch up” may be converting unproductive assets into productive elements of a growing investment portfolio. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS FinancialUnderstanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
https://reachmd.com/programs/medical-industry-feature/mechanism-treatment-approach-indolent-systemic-mastocytosis-ism/32766/Historically, indolent systemic mastocytosis (ISM) care focused on treating symptoms. AYVAKIT® (avapritinib) targets the KIT D816V mutation, the underlying cause of ISM.3,4 Learn how AYVAKIT can play a role in treating patients with ISM.1Weighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://reachmd.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clRefining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
https://reachmd.com/programs/project-oncology/refining-multimodal-therapy-for-mesothelioma-clinical-impact-of-smart-sequencing/36559/Surgery for mesothelioma after radiation therapy (SMART) offers new hope for patients with resectable epithelioid mesothelioma by reversing the traditional treatment sequence. Hear from Dr. John Cho as he discusses the rationale behind this decade-long clinical advancement, which he spoke about at tOptimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
https://reachmd.com/programs/project-oncology/optimizing-nivolumab-in-nsclc-implications-for-cost-access-and-outcomes/32997/Emerging evidence suggests that combining low-dose nivolumab and chemotherapy in the neoadjuvant setting may retain immunologic efficacy while drastically lowering cost and toxicity for non-small cell lung cancer (NSCLC) patients. Additionally, this approach could help optimize trial design with dosCOVID-19 & the 1918 Flu Pandemic: What Can We Learn?
https://reachmd.com/programs/public-health-call/covid-19-the-1918-flu-pandemic-what-can-we-learn/11370/To what extent is COVID-19 different from the 1918 flu pandemic that claimed millions of lives and caused massive social disruption?"Overcoming Obamacare:" Health Policy Perspectives with Author Philip Klein
https://reachmd.com/programs/voices-from-american-medicine/overcoming-obamacare-health-policy-perspectives-author-philip-klein/7284/“One cannot understand policy without appreciating the philosophy that is driving it.” That’s a passage taken from author Philip Klein's book, Overcoming Obamacare: Three Approaches to Reversing the Government Takeover of Health Care. Mr. Klein is commentary editor of the Washington Examiner, whereState of Cancer Care in America from ASCO President Clifford Hudis, MD
https://reachmd.com/programs/focus-on-cancer/state-of-cancer-care-in-america-brfrom-asco-president-clifford-hudis-md/6948/Joining host Dr. Matt Birnholz is special guest, Dr. Clifford A. Hudis, President of the American Society of Clinical Oncology (ASCO) and Chief of the Breast Cancer Medicine Service and an attending physician at Memorial Sloan-Kettering Cancer Center. Dr. Hudis will provide an executive summary of tConference Coverage Highlights From the 2012 Alliance for Continuing Education in the Health Professions (ACEHP) Annual Conference, Part 4
https://reachmd.com/programs/conference-coverage/conference-coverage-highlights-from-the-2012-alliance-for-continuing-education-in-the-health-professions-acehp-annual-conference-part-4/6572/Join host Lawrence Sherman at this year's meeting of the Alliance for Continuing Education in the Health Professions (ACEHP), formerly the Alliance for CME, held on January 21-24, 2012 in Orlando, Florida. His two guests are: Dr. Catherine Grichnik, Director of the Center for Educational ExcellencCellular Vaccine Development as Cancer Therapy
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/cellular-vaccine-development-as-cancer-therapy/4595/What are cellular vaccines and how do they differ from what we think of as conventional vaccines? What are the various types of approaches that we can potentially use for inducing anti-cancer immunity? Dr. Don Siegel, vice chair and professor of pathology and laboratory medicine at Penn Medicine, ta